Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China.
Center for Medical Genetics, School of Life Sciences, Central South University, Changsha, 410008, Hunan, China.
J Neurol. 2018 Mar;265(3):637-646. doi: 10.1007/s00415-018-8743-9. Epub 2018 Jan 25.
Mutations in ganglioside-induced differentiation-associated-protein 1 (GDAP1) have been associated with both subtypes of Charcot-Marie-Tooth (CMT) disease, autosomal recessive (CMT4A and AR-CMT2K) and autosomal dominant (AD-CMT2K). Over 80 different mutations have been identified so far. With the use of Sanger sequencing and Next Generation Sequencing (NGS) technologies, we screened a cohort of 306 unrelated Chinese CMT patients and identified 8 variants in the GDAP1 gene in 4 families, 5 of which were novel (R41H, N201Kfs*5, Q38X, V215I and Q38R). Application of Bioinformatics tool and classification according to the American College of Medical Genetics (ACMG) predicted them of being likely pathogenic with the exception of one variant of uncertain significance (VUS). In addition, we detected the presence of a single heterozygous variant of uncertain significance H256R in one additional family from the CMT cohorts. We found a GDAP1 prevalence rate of 1.63% (5/306). Three families (families 1, 2 and 3) were found to have an autosomal recessive (AR) pattern of inheritance while family 4 displayed an autosomal dominant (AD) mode of inheritance. Electro-physiologic studies revealed an axonal type of neuropathy (AR-CMT2K and AD-CMT2K) in all affected individuals. Clinical characteristics and findings in our study demonstrated that the recessive form presented earlier in life and exhibited severe symptoms and rapid evolution compared to the dominant form. We observed a marked intra-familial variability within the AD family in terms of age at disease onset, symptom severity and clinical progression. Our study expands the mutational spectrum of GDAP1-related CMT disease with the identification of new and unreported GDAP1 variants and demonstrates the predominance of the axonal form of neuropathy in CMT disease associated with GDAP1. We highlight the clinical characteristics associated with these genotypes and describe the relative frequency of GDAP1 variants amongst the Chinese population.
神经节苷脂诱导分化相关蛋白 1(GDAP1)的突变与 Charcot-Marie-Tooth(CMT)疾病的两种亚型有关,常染色体隐性遗传(CMT4A 和 AR-CMT2K)和常染色体显性遗传(AD-CMT2K)。到目前为止,已经发现了 80 多种不同的突变。我们使用 Sanger 测序和下一代测序(NGS)技术对 306 名无关的中国 CMT 患者进行了筛查,并在 4 个家族的 GDAP1 基因中发现了 8 个变体,其中 5 个是新的(R41H、N201Kfs*5、Q38X、V215I 和 Q38R)。生物信息学工具的应用和根据美国医学遗传学学院(ACMG)的分类预测,除了一个意义不确定的变体(VUS)外,这些变体很可能具有致病性。此外,我们在来自 CMT 队列的另一个家族中检测到一个单一的意义不确定的杂合变体 H256R 的存在。我们发现 GDAP1 的患病率为 1.63%(5/306)。三个家族(家族 1、2 和 3)被发现具有常染色体隐性(AR)遗传模式,而家族 4 表现出常染色体显性(AD)遗传模式。电生理研究显示,所有受影响的个体均存在轴索性神经病(AR-CMT2K 和 AD-CMT2K)。我们的研究结果表明,隐性形式在生命早期出现,与显性形式相比,症状严重且快速进展。我们观察到 AD 家族中存在明显的家族内变异性,包括疾病发病年龄、症状严重程度和临床进展。我们的研究扩展了 GDAP1 相关 CMT 疾病的突变谱,发现了新的和未报告的 GDAP1 变体,并证明了 GDAP1 相关 CMT 疾病中轴索性神经病的优势。我们强调了与这些基因型相关的临床特征,并描述了 GDAP1 变体在中国人群中的相对频率。